Cibus Inc. Q4 2025 Earnings Call Transcript Highlights Technology Leadership and Commercialization Progress

Cibus, Inc. (CBUS) reported a landmark year in 2025, with significant advancements in gene editing technology, commercialization progress, scale, and regulatory momentum. The company has seven rice customers with over $200 million in potential annual royalty opportunity, received its first customer payment from the sustainable ingredients program, and was selected by the UK government as a technology partner for its farming innovation program. Cibus has shifted to a commercially driven company with a powerful technology engine, enabling seed companies to integrate its gene editing technologies into their breeding programs on a predictable schedule.